Skip to main content

A poster abstract presented at American Academy of Dermatology Virtual Meeting Experience 2021 found that consumers with various dermat

Upadacitinib, a selective and orally available Janus kinase 1 (JAK-1) inhibitor, has demonstrated significant reduction in disease seve

The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is

Jason Bok Lee, MD, discussed approaches to melanoma diagnosis prior to his session at AAD VMX referencing the NEJM article entitled, “The Rapid Rise in Cutaneous Melanoma Diagnoses”.
During the What’s New in Skin of Color session at AAD VMX 2021, Seemal R. Desai, MD, FAAD discussed the skin bleaching epidemic, a growing issue seen in patients of color.
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
David Rosmarin, MD, shares the results of recent studies into ruxolitinib cream for the treatment of vitiligo in a video interview, including current AAD VMX abstracts.
A poster abstract presented at American Academy of Dermatology Virtual Meeting Experience 2021 found that cellular lineage and nomenclature were poor indicators of ADA development and clinical efficacy.
In one of the “Complex Medical Dermatology” presentations at AAD VMX 2021, Erik Stratman, MD, sifted through the fact or fiction regarding the use and safety of certain drugs in patients with psoriasis.
At the AAD VMX 2021, Richard G.B. Langley, MD, explained the reasons why dermatologists should consider stepping up their patients with mild to moderate psoriasis to a systemic therapy.
Back to Top